What Does 'Estrogen Receptor Positive' Actually Mean? A Naturopath's Explanation
There's a particular moment in an oncologist's office that almost everyone describes the same way afterward. You're still absorbing the word "cancer," and then a second phrase arrives that you're somehow expected to understand: "the good news is, it's estrogen receptor positive." You nod. You have no idea what that means. You go home and search what does estrogen receptor positive mean, and you land in a sea of clinical pages that explain the what and almost never the why.
This is the post I wish every woman could read on the drive home. I'm a naturopath, not your oncologist — your treatment decisions belong with your medical team, full stop. But translating what the oncologist said into something you can actually picture is squarely my job, and there's a way of seeing estrogen that makes the whole conversation click into place. Let me give it to you.
Estrogen has a three-part life: make it, use it, clear it
Picture estrogen moving through your body in three stages.
You make it. In younger women, mostly from the ovaries. After menopause, the bigger source is often an enzyme called aromatase sitting in your fat tissue and other organs, converting other hormones into estrogen. Remember that word — aromatase — it's about to matter.
You use it. Estrogen doesn't do anything floating in your blood. It works by plugging into a receptor — think lock and key — and that receptor sits inside the cell. When estrogen turns the lock, it sends an instruction. In many tissues that instruction is, essentially, grow.
You clear it. Once estrogen has done its job, the body has to package it up and get rid of it through the liver and gut. (More on that third step shortly — it's the part nobody mentions.)
Hold that shape in your head — make, use, clear — because "estrogen receptor positive" is a statement about the middle one.
So what does "estrogen receptor positive" actually mean?
When a pathologist looks at your tumour, one of the things they test is whether its cells are carrying those estrogen receptors — the locks. If the cells are studded with them, the tumour is labelled estrogen receptor positive (ER+). If not, ER negative.
ER+ means the tumour's growth is, at least partly, fuelled by estrogen plugging into those receptors and telling it to grow. That's the whole concept. The cancer has, in effect, tapped into one of your body's normal signalling lines and is using it as an accelerator.
And here's the part that makes "the good news" make sense — the deep cut most people miss in the appointment. Around 70–80% of breast cancers are ER positive, making it by far the most common type. It also tends to carry a better outlook than ER-negative disease, for a counter-intuitive reason: a cancer with a known fuel source is a cancer with a target. If you know what's feeding it, you have something specific to take away. ER-negative cancers don't hand you that lever. So when your oncologist called it good news, they meant it literally — your cancer told them how to fight it.
Why your treatment makes sense once you see the lifecycle
Here's where the make/use/clear picture pays off, because the two main hormone therapies oncologists use for ER+ breast cancer each target a different step — and once you see that, the plan stops feeling random.
Tamoxifen blocks the "use" step. It's what's called a selective estrogen receptor modulator. Picture it sitting in the lock so estrogen's key can't turn it. The estrogen is still there, circulating — tamoxifen just stops it from delivering the "grow" message to the breast tissue. That's why it's often used in younger women whose ovaries are still making plenty of estrogen: you can't easily switch off the supply, so you block the receiver instead.
Aromatase inhibitors block the "make" step. Remember aromatase, the enzyme in fat tissue that builds estrogen after menopause? These drugs (anastrozole, letrozole, exemestane) switch that enzyme down, so far less estrogen gets made in the first place. There's almost nothing to plug into the receptor. This is why they're used mainly in postmenopausal women — where aromatase, not the ovaries, is the main source.
Same disease, two doors, two different steps of the same lifecycle. Neither is "natural" or "alternative" — they're both elegant, targeted medicine, and for ER+ breast cancer they are central. Nothing I do replaces them.
What nobody explains in the appointment: the third leg, "clear it"
Now the part the oncology visit almost never has time for, and where my lens genuinely adds something.
Your body doesn't just make and use estrogen — it has to clear it, and how it clears it is biochemistry you can influence at the edges. When the liver breaks estrogen down, it sends it down one of three roads. One road (the "2-OH" pathway) is calm and easily disposed of. Another (the "4-OH" pathway) produces by-products that can actually damage DNA if the body doesn't neutralise them quickly — which is exactly the kind of damage that matters in cancer biology. The body neutralises that hazardous road through a process called methylation (which runs on everyday nutrients — magnesium, B12, folate, B6) and through compounds like the sulforaphane found in broccoli sprouts, plus the gut.
And the gut is the twist. A population of gut bacteria — the estrobolome — makes an enzyme (beta-glucuronidase) that can un-package estrogen the liver had already bound for disposal, sending it back into circulation. Your liver does the clearing; an imbalanced gut can quietly undo it.
I'm not telling you this so you'll go buy something. I'm telling you because it explains why an integrative practitioner working alongside your oncologist looks at your sleep, your gut, your nutrient status and your liver — not as a treatment for the cancer, but as the terrain the whole system runs in. Conventional therapy works the make and use steps brilliantly. The clear step is part of the wider picture of your overall health, and it's a legitimate place for supportive care.
The most important safety thing on this page
If you take one practical message from this, take this one: do not start supplements on your own during hormone therapy for ER+ breast cancer. This is not me being cautious for the sake of it — there are real, specific reasons.
Some supplements change how your liver activates or clears your medication. Tamoxifen, for instance, has to be switched on by a liver enzyme (CYP2D6) into its active form — and certain supplements and even some antidepressants can interfere with that activation, potentially blunting the drug that's protecting you. "Estrogen-detox" products sold for hormone balance can be exactly the wrong thing in the wrong hands.
The right model is a team: your oncologist runs the cancer treatment, and an integrative practitioner experienced in oncology supports the terrain in coordination with them — checking that nothing you add works against what you're taking. That coordination is the entire value. Going solo with a cupboard of supplements is where good intentions cause harm.
What this means for you
If you're sitting with a new ER+ diagnosis, here's the reframe to carry: your cancer is the common, well-understood, highly targetable kind, and your treatment is aimed precisely at the estrogen lifecycle we just walked through. The foundations that support your overall health and resilience through treatment — nourishing whole-food eating, a gut you look after, sleep in genuine darkness, gentle movement as you're able, and steady support for your nervous system through a hard season — are things you can begin to think about with your team, and they sit alongside your oncology care, never in place of it.
What a Naturopathic consultation can do is help you understand your own hormone and terrain picture in detail, and make sure every supportive choice is coordinated with your medical treatment rather than quietly competing with it. That's the work — and it's best done with your whole team.
The honest bottom line
Estrogen receptor positive" isn't a verdict to fear — it's information, and it's usually the more hopeful kind. It means your cancer revealed its fuel line, and modern hormone therapy is very good at cutting that line off, whether by blocking where estrogen is made or where it's used. Understanding the third step — how your body clears estrogen — won't replace any of that, but it will help you see why your integrative team cares about your gut, your liver, and your nutrients, and it will help you ask sharper questions of everyone treating you. That understanding is yours to keep.
FURTHER READING
-
American Cancer Society — Breast Cancer Hormone Receptor Status. https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-hormone-receptor-status.html
-
Breast Cancer Research Foundation — Estrogen Receptor-Positive Breast Cancer: The Most Common Subtype. https://www.bcrf.org/blog/estrogen-receptor-positive-breast-cancer-the-most-common-subtype/
-
Cleveland Clinic — Estrogen Receptor-Positive (ER+) Breast Cancer. https://my.clevelandclinic.org/health/diseases/er-positive-breast-cancer
-
Role of aromatase inhibitors in breast cancer — review (mechanism). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361691/
-
Estrogen metabolism pathways (2-OH/4-OH) and clinical relevance — review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556476/
This article is educational and reflects an integrative naturopathic perspective on understanding a breast cancer diagnosis. It is not medical advice and is not intended to diagnose, treat, cure or prevent any disease. Treatment for estrogen receptor positive breast cancer is directed by your oncology team, and hormone therapies such as tamoxifen and aromatase inhibitors are central to that care. Do not start, stop, or change any prescribed medication, and do not add any supplement during cancer treatment, without your treating clinicians' involvement — some supplements interact with these medications. Any complementary or supportive care should be coordinated with your oncologist.